State of Wisconsin Investment Board’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

State of Wisconsin Investment Board’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,700	Closed	-$359K	–	2107
2020 Q4	$359K	Sell	18,700 -2,300	-11%	-$35.5K	﹤0.01%	1638
2020 Q3	$282K	Buy	21,000 +5,100	+32%	+$144K	﹤0.01%	1852
2020 Q2	$673K	Sell	15,900 -2,700	-15%	-$87.4K	﹤0.01%	1338
2020 Q1	$514K	Buy	18,600 +7,000	+60%	+$204K	﹤0.01%	1346
2019 Q4	$376K	Hold	11,600	–	–	﹤0.01%	1512
2019 Q3	$302K	Buy	11,600 +2,400	+26%	+$80.3K	﹤0.01%	1446
2019 Q2	$338K	Buy	+9,200	New	+$220K	﹤0.01%	1419

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

State of Wisconsin Investment Board's ODT Position: Q1 2021 in Review

State of Wisconsin Investment Board sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 18,700 shares — an estimated $359K sold.

State of Wisconsin Investment Board first reported a position in ODT in Q2 2019 and held it in 7 quarters. The position peaked at $673K in Q2 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

State of Wisconsin Investment Board reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 18,700 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $359K.
State of Wisconsin Investment Board first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
State of Wisconsin Investment Board's Odonate Therapeutics, Inc. Common Stock position peaked at $673K in Q2 2020.
83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2021, filed 17 May 2021.